Attenuation Correction: CT Topogram

  • Research type

    Research Study

  • Full title

    Use of the CT Scout View (Topogram) for Accurate Attenuation Correction and Quantification of Nuclear Medicine Planar Studies.

  • IRAS ID

    236139

  • Contact name

    Gregory James

  • Contact email

    gregory.james@nhs.net

  • Sponsor organisation

    Sandwell and West Birmingham Hospitals NHS Trust

  • ISRCTN Number

    ISRCTN00000000

  • Clinicaltrials.gov Identifier

    NCT00000000

  • Clinicaltrials.gov Identifier

    N/A, N/A

  • Duration of Study in the UK

    3 years, 0 months, 1 days

  • Research summary

    When a patient attends a nuclear medicine department for a scan, the patient is injected with a radioactive tracer which is taken up by various organs in the body, depending on what the clinician wants to study. The tracer gives off gamma radiation which is detected and imaged by a scanner called a gamma camera. Many of the gamma rays given off from the tracer are ‘stopped’ in the patient’s body before they reach the gamma camera to produce the image. This is called ‘attenuation’ and is problematic in nuclear medicine as it can lead to underestimation of the amount of uptake in the organ and give the clinician false information. It is therefore important to compensate for the gamma-rays that have been ‘stopped’ (or attenuated) in the body for accurate organ uptake measurement.

    The compensation technique we use in nuclear medicine is called ‘attenuation correction’ where a CT scanner is used to get detailed images of the patient’s anatomy. Computer software can then perform the necessary corrections and produce images that represent the true uptake of tracer in the body. However, this technique is only used in 3-dimensional imaging and is yet to be widely implemented for 2-dimensional imaging due to problems with out-of-date methods and a lack of commercial solutions.

    This study is researching if it is possible to use a CT scanner in a novel way to perform attenuation correction for 2-dimensional nuclear medicine imaging. If successful, we will be able to accurately quantify organ uptake of tracers using 2-dimensional nuclear medicine imaging when 3-dimensional imaging is not practical.

  • REC name

    West Midlands - Edgbaston Research Ethics Committee

  • REC reference

    19/WM/0175

  • Date of REC Opinion

    12 Aug 2019

  • REC opinion

    Further Information Favourable Opinion